Neurostructural predictors of Alzheimer's disease: A meta-analysis of VBM studies

Neurobiology of Aging

Volumn 32, Issue 10, 2011, Pages 1733-1741

  Ferreira, Luiz K ^a   Diniz, Breno S ^a   Forlenza, Orestes V ^a   Busatto, Geraldo F ^a   Zanetti, Marcus V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Activation likelihood estimation; Alzheimer's disease; Meta analysis; Mild cognitive impairment; MRI; Systematic review; Voxel based morphometry

Indexed keywords

ALZHEIMER DISEASE; AMNESTIC MILD COGNITIVE IMPAIRMENT; BRAIN ATROPHY; BRAIN SIZE; DISEASE COURSE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAHIPPOCAMPAL GYRUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TEMPORAL LOBE; VOXEL BASED MORPHOMETRY;

ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; HUMANS; NEUROIMAGING; PREDICTIVE VALUE OF TESTS;

EID: 80051571545     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.11.008     Document Type: Review

References (49)

1. Apostolova L.G., Dutton R.A., Dinov I.D., Hayashi K.M., Toga A.W., Cummings J.L., Thompson P.M. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch. Neurol. 2006, 63:693-699.
2. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11:805-821.
3. Ashburner J. Computational anatomy with the SPM software. Magn. Reson. Imag. 2009, 27:1163-1174.
4. Bakkour A., Morris J.C., Dickerson B.C. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 2009, 72:1048-1055.
5. Bell-McGinty S., Lopez O.L., Meltzer C.C., Scanlon J.M., Whyte E.M., Dekosky S.T., Becker J.T. Differential cortical atrophy in subgroups of mild cognitive impairment. Arch. Neurol. 2005, 62:1393-1397.
6. Bozzali M., Filippi M., Magnani G., Cercignani M., Franceschi M., Schiatti E., Castiglioni S., Mossini R., Falautano M., Scotti G., Comi G., Falini A. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology 2006, 67:453-460.
7. Braak E., Griffing K., Arai K., Bohl J., Bratzke H., Braak H. Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249(Suppl. 3):14-22.
8. Brys M., Glodzik L., Mosconi L., Switalski R., De Santi S., Pirraglia E., Rich K., Kim B.C., Mehta P., Zinkowski R., Pratico D., Wallin A., Zetterberg H., Tsui W.H., Rusinek H., Blennow K., de Leon M.J. Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease. J. Alzheimers Dis. 2009, 16:351-362.
9. Busatto G.F., Diniz B.S., Zanetti M.V. Voxel-based morphometry in Alzheimer's disease. Expert Rev. Neurother. 2008, 8:1691-1702.
10. Busse A., Hensel A., Guhne U., Angermeyer M.C., Riedel-Heller S.G. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 2006, 67:2176-2185.
11. Caroli A., Testa C., Geroldi C., Nobili F., Barnden L.R., Guerra U.P., Bonetti M., Frisoni G.B. Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment. J. Neurol. 2007, 254:1698-1707.
12. Chetelat G., Baron J.C. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage 2003, 18:525-541.
13. Chetelat G., Landeau B., Eustache F., Mezenge F., Viader F., de la Sayette V., Desgranges B., Baron J.C. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 2005, 27:934-946.
14. Cummings J.L., Doody R., Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology 2007, 69:1622-1634.
15. Diniz B.S., Pinto Junior J.A., Forlenza O.V. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J. Biol. Psychiatry 2008, 9:172-182.
16. Diniz B.S., Nunes P.V., Yassuda M.S., Forlenza O.V. Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study. Dement. Geriatr. Cogn. Disord. 2009, 27:224-231.
17. Du A.T., Schuff N., Amend D., Laakso M.P., Hsu Y.Y., Jagust W.J., Yaffe K., Kramer J.H., Reed B., Norman D., Chui H.C., Weiner M.W. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2001, 71:441-447.
18. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007, 6:734-746.
19. Eickhoff S.B., Laird A.R., Grefkes C., Wang L.E., Zilles K., Fox P.T. Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty. Hum. Brain Mapp. 2009, 30:2907-2926.
20. Ellison-Wright I., Ellison-Wright Z., Bullmore E. Structural brain change in attention deficit hyperactivity disorder identified by meta-analysis. BMC Psychiatry 2008, 30:51.
21. Fan Y., Shen D., Gur R.C., Gur R.E., Davatzikos C. COMPARE: classification of morphological patterns using adaptive regional elements. IEEE Trans. Med. Imag. 2007, 26:93-105.
22. Farias S.T., Mungas D., Reed B.R., Harvey D., DeCarli C. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch. Neurol. 2009, 66:1151-1157.
23. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
24. Forlenza O.V., Chiu E. Mild cognitive impairment: a concept ready to move on?. Curr. Opin. Psychiatry 2008, 21:529-532.
25. Forlenza, O.V., Diniz, B.S., Nunes, P.V., Memória, C.M., Yassuda, M.S., Gattaz, W.F., Diagnostic transitions in mild cognitive impairment subtypes. Int. Psychogeriatrics. doi:10.1017/S1041610209990792.
26. Glahn D.C., Laird A.R., Ellison-Wright I., Thelen S.M., Robinson J.L., Lancaster J.L., Bullmore E., Fox P.T. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol. Psychiatry 2008, 64:774-781.
27. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001, 14:21-36.
28. Hall A.M., Moore R.Y., Lopez O.L., Kuller L., Becker J.T. Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease. Alzheimers Dement. 2008, 4:271-279.
29. Jack C.R., Shiung M.M., Gunter J.L., O'Brien P.C., Weigand S.D., Knopman D.S., Boeve B.F., Ivnik R.J., Smith G.E., Cha R.H., Tangalos E.G., Petersen R.C. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004, 62:591-600.
30. Jagust W., Reed B., Mungas D., Ellis W., Decarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?. Neurology 2007, 69:871-877.
31. Karas G., Sluimer J., Goekoop R., van der Flier W., Rombouts S.A., Vrenken H., Scheltens P., Fox N., Barkhof F. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am. J. Neuroradiol. 2008, 29:944-949.
32. Laird A.R., Fox P.M., Price C.J., Glahn D.C., Uecker A.M., Lancaster J.L., Turkeltaub P.E., Kochunov P., Fox P.T. ALE meta-analysis: controlling the false discovery rate and performing statistical contrasts. Hum. Brain Mapp. 2005, 25:155-164.
33. Mahley R.W., Weisgraber K.H., Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5644-5651.
34. Mitchell A.J., Shiri-Feshki M. Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis. J. Neurol. Neurosurg. Psychiatry 2008, 79:1386-1391.
35. Morbelli, S., Piccardo, A., Villavecchia, G., Dessi, B., Brugnolo, A., Piccini, A., Caroli, A., Frisoni, G., Rodriguez, G., Nobili, F., Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study. Eur. J. Nucl. Med. Mol. Imag. doi:10.1007/s00259-009-1218-6.
36. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004, 256:183-194.
37. Ries M.L., Carlsson C.M., Rowley H.A., Sager M.A., Gleason C.E., Asthana S., Johnson S.C. Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J. Am. Geriatr. Soc. 2008, 56:920-934.
38. Risacher S.L., Saykin A.J., West J.D., Shen L., Firpi H.A., McDonald B.C. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr. Alzheimer Res. 2009, 6:347-361. Alzheimer's Disease Neuroimaging Initiative (ADNI).
39. Scahill R.I., Schott J.M., Stevens J.M., Rossor M.N., Fox N.C. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:4703-4707.
40. Schroeter M.L., Raczka K., Neumann J., von Cramon D.Y. Neural networks in frontotemporal dementia-a meta-analysis. Neurobiol. Aging 2008, 29:418-426.
41. Schroeter M.L., Stein T., Maslowski N., Neumann J. Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 2009, 47:1196-1206.
42. Small G.W., Kepe V., Ercoli L.M., Siddarth P., Bookheimer S.Y., Miller K.J., Lavretsky H., Burggren A.C., Cole G.M., Vinters H.V., Thompson P.M., Huang S.C., Satyamurthy N., Phelps M.E., Barrio J.R. PET of brain amyloid and tau in mild cognitive impairment. N. Engl. J. Med. 2006, 355:2652-2663.
43. Testa C., Laakso M.P., Sabattoli F., Rossi R., Beltramello A., Soininen H., Frisoni G.B. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease. J. Magn. Reson. Imag. 2004, 19:274-282.
44. Thompson P.M., Hayashi K.M., de Zubicaray G., Janke A.L., Rose S.E., Semple J., Herman D., Hong M.S., Dittmer S.S., Doddrell D.M., Toga A.W. Dynamics of gray matter loss in Alzheimer's disease. J. Neurosci. 2003, 23:994-1005.
45. Turkeltaub P.E., Eden G.F., Jones K.M., Zeffiro T.A. Meta-analysis of the functional neuroanatomy of single-word reading: method and validation. Neuroimage 2002, 16:765-780.
46. Villain N., Desgranges B., Viader F., de la Sayette V., Mézenge F., Landeau B., Baron J.C., Eustache F., Chételat G. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J. Neurosci. 2008, 28:6174-6181.
47. Waragai M., Okamura N., Furukawa K., Tashiro M., Furumoto S., Funaki Y., Kato M., Iwata R., Yanai K., Kudo Y., Arai H. Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease. J. Neurol. Sci. 2009, 285:100-108.
48. Whitwell J.L., Przybelski S.A., Weigand S.D., Knopman D.S., Boeve B.F., Petersen R.C., Jack C.R. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 2007, 130:1777-1786.
49. Whitwell J.L., Shiung M.M., Przybelski S.A., Weigand S.D., Knopman D.S., Boeve B.F., Petersen R.C., Jack C.R. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008, 70:512-520.